News highlights:

• Deploys BioPrinters to four major research facilities:

_° Spanish National Research Council (CSIC) (Spain), the largest and leading public research institution in Spain.
_° Center for Nuclear Receptors and Cell Signaling (CNRCS) at University of Houston (U.S.), which conducts a wide range of cutting-edge research to develop therapeutics for various diseases including viral diseases, cancer, neurodegenerative diseases and metabolic diseases.
_° Monoclonal Antibody Discovery Laboratory at Fondazione Toscana Life Sciences (Italy), which focuses on monoclonal antibody (mAb) discovery against infectious diseases.
_° Grenoble Alpes University Hospital (CHUGA) (France), one of the largest research and teaching hospitals in France, which focuses on diagnosis and follow-up of acute or chronic human viral infections.

PALO ALTO, Calif., July 13, 2020 (GLOBE NEWSWIRE)

FORT DODGE, Iowa, July 13, 2020 (GLOBE NEWSWIRE)

NAPLES, Fla., July 13, 2020 (GLOBE NEWSWIRE)

SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE)

SOUTH SAN FRANCISCO, Calif., July 13, 2020 (GLOBE NEWSWIRE)

SOUTH SAN FRANCISCO, Calif., July 13, 2020 (GLOBE NEWSWIRE)

Update on COVID-19: CytoDyn is planning to lock and unblind the Phase 2 COVID-19 trial data later this week. Periodic safety review by Data Safety Monitoring Committee (DSMC) for ongoing Phase 3 study (severe/critical population) is planned for next week. Both results to be announced in July

CytoDyn holds investment community call today, Monday, July 13 at 1:00 pm PT

VANCOUVER, Washington, July 13, 2020 (GLOBE NEWSWIRE)

OLDSMAR, Fla., July 10, 2020 (GLOBE NEWSWIRE)

LOS ANGELES, July 10, 2020 (GLOBE NEWSWIRE)

Westport, CT, July 10, 2020 (GLOBE NEWSWIRE)

TAMPA, Fla., July 10, 2020 (GLOBE NEWSWIRE)

Full Year Revenue of Approximately $62.3 Million

Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies

FARMINGDALE, N.Y., July 10, 2020 (GLOBE NEWSWIRE)

SCOTTSDALE, Ariz., July 09, 2020 (GLOBE NEWSWIRE)

Rockville, MD, USA, July 09, 2020 (GLOBE NEWSWIRE)

PHOENIX, July 09, 2020 (GLOBE NEWSWIRE)